Healthcare [ 12/13 ] | Medical Care Facilities [ 83/164 ]
NASDAQ | Common Stock
Option Care Health, Inc. offers home and alternate site infusion services in the United States.
The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.
The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.
Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 23, 24 | 0.26 Increased by +23.81% | 0.23 Increased by +13.04% |
| Feb 22, 24 | 0.32 Increased by +45.45% | 0.29 Increased by +10.34% |
| Oct 25, 23 | 0.31 Increased by +47.62% | 0.28 Increased by +10.71% |
| Jul 27, 23 | 0.63 Increased by +231.58% | 0.22 Increased by +186.36% |
| May 3, 23 | 0.21 Increased by +23.53% | 0.18 Increased by +16.67% |
| Feb 23, 23 | 0.22 Decreased by -46.34% | 0.22 |
| Oct 27, 22 | 0.21 Increased by +5.00% | 0.21 |
| Jul 27, 22 | 0.19 Increased by +5.56% | 0.22 Decreased by -13.64% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 1.15 B Increased by +12.82% | 44.79 M Increased by +14.24% | Increased by +3.91% Increased by +1.26% |
| Dec 31, 23 | 1.12 B Increased by +9.46% | 57.18 M Increased by +20.30% | Increased by +5.09% Increased by +9.90% |
| Sep 30, 23 | 1.09 B Increased by +7.06% | 56.30 M Increased by +45.02% | Increased by +5.15% Increased by +35.46% |
| Jun 30, 23 | 1.07 B Increased by +9.00% | 114.40 M Increased by +237.18% | Increased by +10.70% Increased by +209.35% |
| Mar 31, 23 | 1.02 B Increased by +10.93% | 39.21 M Increased by +29.51% | Increased by +3.86% Increased by +16.75% |
| Dec 31, 22 | 1.03 B Increased by +10.79% | 47.53 M Decreased by -37.02% | Increased by +4.63% Decreased by -43.15% |
| Sep 30, 22 | 1.02 B Increased by +14.46% | 38.82 M Increased by +9.43% | Increased by +3.80% Decreased by -4.39% |
| Jun 30, 22 | 980.82 M Increased by +14.01% | 33.93 M Increased by +6.64% | Increased by +3.46% Decreased by -6.47% |